Company News

FDA Extends Juvaderm’s Scope

Allergan's injectable OK'd for lip area.

Author Image

By: Christine Esposito

Editor-in-Chief

Allergan plc, has received approval from the U.S. FDA to market Juvederm Ultra XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21.   “As the leader in medical aesthetics, Allergan is committed to continued research and development in this area,” said Philippe Schaison, EVP & president, Allergan Medical. “With this approval, Juvederm Ultra XC is now the only filler that is approved to last up to one year in the lips while prov...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters